Plasmablastic Lymphoma
generalAn aggressive diffuse large B-cell lymphoma frequently arising in the setting of HIV infection and characterized by the presence of large neoplastic cells resembling B-immunoblasts which have the immunophenotypic profile of plasma cells. Sites of involvement include the oral cavity, sinonasal cavity, skin, soft tissues, gastrointestinal tract, and bone.
38
Centers
38
Active Trials
$5M
Cancer Funding
Specific Cancer Types(1)
| Name | Centers |
|---|---|
| Recurrent Plasmablastic Lymphoma | 4 |
Top Centers for Plasmablastic Lymphoma(38)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive High-Volume Research Center | 72.3 |
| 2 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive High-Volume Research Center | 71.3 |
| 3 | Duke Cancer InstituteDurham, NC NCI Comprehensive High-Volume Research Center | 70.4 |
| 4 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program | 67.6 |
| 5 | NCI Comprehensive Active Research Program | 67.6 |
| 6 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 67.6 |
| 7 | NCI Clinical Active Research Program | 67.6 |
| 8 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 67.6 |
| 9 | University of Illinois Cancer CenterChicago, IL Active Research Program | 67.6 |
| 10 | Cancer Center at IllinoisUrbana, IL Active Research Program | 67.6 |
| 11 | NCI Comprehensive Active Research Program | 53.4 |
| 12 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 53.4 |
| 13 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 53.4 |
| 14 | NCI Comprehensive Active Research Program | 53.4 |
| 15 | NCI Comprehensive Active Research Program | 53.4 |
| 16 | NCI Comprehensive Active Research Program | 53.4 |
| 17 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 53.4 |
| 18 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 53.4 |
| 19 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 53.4 |
| 20 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 53.4 |
| 21 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 53.4 |
| 22 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program | 53.4 |
| 23 | Boston University Cancer CenterBoston, MA Active Research Program | 53.4 |
| 24 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 53.4 |
| 25 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 53.4 |
| 26 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 35.6 |
| 27 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive | 35.6 |
| 28 | NCI Comprehensive | 35.6 |
| 29 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 35.6 |
| 30 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | 35.6 |
| 31 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive | 35.6 |
| 32 | NCI Comprehensive | 35.6 |
| 33 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | 35.6 |
| 34 | Cleveland Clinic Cancer CenterCleveland, OH | 35.6 |
| 35 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive | 35.6 |
| 36 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical | 35.6 |
| 37 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive | 35.6 |
| 38 | Louisiana Cancer Research CenterNew Orleans, LA | 35.6 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →